Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pharmacodynamic Interactions of Alcohol and Opioids
NCT04300751Phase 1Completed
- Start
- Mar 2021
- Primary completion
- Nov 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, triple-blind trial of oxycodone in opioid use disorder (OUD) and alcohol use disorder (AUD) (3 arms). Primary endpoint: Visual Analog Scale Drug Liking at 6.5 hours. Started Mar 2021; status: completed.
02
Drugs
oxycodone
03
Conditions
opioid use disorder (OUD)alcohol use disorder (AUD)
Beyond the preview
Go deeper on NCT04300751.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04300751.